BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18240961)

  • 21. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
    Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
    Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
    Yu J; Liang C; Liu SL
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation.
    Fong L; Mengozzi M; Abbey NW; Herndier BG; Engleman EG
    J Virol; 2002 Nov; 76(21):11033-41. PubMed ID: 12368346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro.
    Vassiliadou N; Tucker L; Anderson DJ
    J Immunol; 1999 Jun; 162(12):7510-8. PubMed ID: 10358206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes.
    Patterson BK; Czerniewski M; Andersson J; Sullivan Y; Su F; Jiyamapa D; Burki Z; Landay A
    Clin Immunol; 1999 Jun; 91(3):254-62. PubMed ID: 10370370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
    Agrawal L; Vanhorn-Ali Z; Alkhatib G
    J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates.
    Mörner A; Björndal A; Leandersson AC; Albert J; Björling E; Jansson M
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):193-200. PubMed ID: 11839153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
    Maritz MF; Ray RM; Bick AJ; Tomasicchio M; Woodland JG; Govender Y; Avenant C; Hapgood JP
    PLoS One; 2018; 13(4):e0196043. PubMed ID: 29698514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.
    Fakruddin JM; Lempicki RA; Gorelick RJ; Yang J; Adelsberger JW; Garcia-Pineres AJ; Pinto LA; Lane HC; Imamichi T
    Blood; 2007 Mar; 109(5):1841-9. PubMed ID: 17068156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
    Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
    J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of anti-HIV-1 activity of a new iridoid glycoside isolated from Avicenna marina, in vitro.
    Behbahani M
    Int Immunopharmacol; 2014 Nov; 23(1):262-6. PubMed ID: 25239814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.
    Anton PA; Elliott J; Poles MA; McGowan IM; Matud J; Hultin LE; Grovit-Ferbas K; Mackay CR; Chen ISY ; Giorgi JV
    AIDS; 2000 Aug; 14(12):1761-5. PubMed ID: 10985313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
    Shirazi Y; Pitha PM
    J Hum Virol; 1998; 1(2):69-76. PubMed ID: 10195234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies.
    Zhang D; Murakami A; Johnson RP; Sui J; Cheng J; Bai J; Marasco WA
    J Acquir Immune Defic Syndr; 2003 Mar; 32(3):245-54. PubMed ID: 12626883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coreceptors CCR5 and CXCR4 expressions on peripheral blood T lymphocytes in HIV/AIDS patients].
    Zhao W; Wu YW; Liu W; Yao WH; Zhao H
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):574-6, 580. PubMed ID: 16138573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells.
    Shapira-Nahor O; Maayan S; Peden KW; Rabinowitz R; Schlesinger M; Alian A; Panet A
    Virology; 2002 Nov; 303(1):138-45. PubMed ID: 12482665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of alternative coreceptor use by pediatric HIV-1 R5 isolates for infection of primary cord or adult peripheral blood mononuclear cells.
    Sullivan WM; Dorr P; Perros M; Hudson R; Leif J; Luzuriaga K; Clapham PR
    Arch Virol; 2008; 153(2):363-6. PubMed ID: 18074097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells.
    Vicenzi E; Panina-Bodignon P; Vallanti G; Di Lucia P; Poli G
    J Leukoc Biol; 2002 Nov; 72(5):913-20. PubMed ID: 12429712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivo.
    Agrawal L; Jin Q; Altenburg J; Meyer L; Tubiana R; Theodorou I; Alkhatib G
    J Virol; 2007 Aug; 81(15):8041-9. PubMed ID: 17522201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.